AstraZeneca PLC (AZNs)

1,236.60
-6.50(-0.53%)
  • Volume:
    314,735
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    1,225.50 - 1,245.00

AZNs Overview

Prev. Close
1,232
Day's Range
1,225.5-1,245
Revenue
379.26B
Open
1,240
52 wk Range
925.02-1,447.92
EPS
-0.816
Volume
314,735
Market Cap
1.89T
Dividend (Yield)
221.70
(2.25%)
Average Vol. (3m)
194,967
P/E Ratio
-159.09
Beta
0.119
1-Year Change
18.1%
Shares Outstanding
1,549,508,944
Next Earnings Date
Nov 10, 2022
What is your sentiment on AstraZeneca?
or
Market is currently closed. Voting is open during market hours.

AstraZeneca PLC News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

AstraZeneca PLC Analysis

AstraZeneca PLC Company Profile

AstraZeneca PLC Company Profile

Employees
83100
  • Type:Equity
  • Market:Sweden
  • ISIN:GB0009895292

AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 177 projects, of which 161 are in the clinical phase of development. Its key marketed oncology products include Tagrisso (osimertinib), Lynparza (olaparib), Imfinzi (durvalumab), Koselugo (selumetinib), Farxiga/ Forxiga (dapagliflozin), Roxadustat, Onglyza (saxagliptin) and others. The Company’s geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyNeutralSellBuy
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Buy
  • Pfizer and Moderna fell big time in share prices, while Astra kept it’s stable 9ish. How?
    1
    • money to get
      0
    • hello please help you
      1
    • Attila, AZ & Pfizer are pharmaceutical companies that makes medicines. They are not just providers of vaccines. At present, and for the foreseeable future, the AZ science is much stronger than that of Pfizer, and similar to Merck, which is another pharmaceutical company that has grown materially this year. I am long on AZ and Merck.
      0
  • An attractive PRE-IPO called SpectrumX based in England plans to launch by November and i'm very hopeful of this particular investment. Clinical trials for their Covid-19 respiratory treatment are now in phase 2 of development which will be a game changer once hospitals get their hands on it. This will not be factored into the company valuation when listed. So if the trials are successful the market value will rocket. Thats why im seriously excited about this IPO and i don't usually go near PRE IPO's.
    4
    • how's it doing today
      0
    • how's it doing today
      0
  • 50
    0
    • *50000
      0
  • 19970410🌍 10000%
    0
    • Most of vunerable demographic now vaccinated. Will younger people accept the jab or will potential health concerns outweigh the potential benefits. I'm short AstraZeneca
      5
      • net short positions available on the PNC Borsa app
        0
        • Above 7500 to 9750 soon these weeks bullish sentiments business development infrastructure expenditures stimulus package cause its stance growth economics of scales
          2
          • you are nostetadamoos
            1
        • may be buy or sell the stock but be very cautious before being vaccinated : some serious cases in Europe especially with young to intermediate people
          11
          • GP GAPYes Im chief nurse teacher in a very big hospital. Not specialised in vaccine but i know a little bit about heath. And im a pro vaccine. But the rule we were givenby health autorities  was : Astra not for people under 55.
            1
          • Thanks for the advise.
            0
          • Jenny Goughlike dada
            0
        • This is moving now....at last! US approval coming.
          1
          • The cause behind the suspected vaccine side effects has been found. This is the opinion of a Norwegian expert group that examined the three healthcare employees who were admitted to hospital after being vaccinated with Astra Zeneca's vaccine. The vaccine triggered a strong immune reaction in the people. - I see no other reason than that it is the vaccine that triggers it, says the chief physician and professor Pål Andre Holme to VG. Sell off coming
            5
            • I guess that puts this Professor at odds with all the others looking at the data then.   Strange they were all healthcare employees.
              0
            • u shorting?
              1